Skeletal muscle retains a resident stem cell population called satellite cells. Although mitotically quiescent in mature muscle, satellite cells can be activated to produce myoblast progeny to generate myonuclei for skeletal muscle homoeostasis, hypertrophy and repair. Regulation of satellite cell function in adult requires redeployment of many of the regulatory networks fundamental to developmental myogenesis. Involved in such control of muscle stem cell fate in embryos are members of the Pitx gene family of bicoid-class homeodomain proteins. Here, we investigated the expression and function of all three Pitx genes in muscle satellite cells of adult mice. Endogenous Pitx1 was undetectable, whilst Pitx2a, Pitx2b and Pitx2c were at low levels in proliferating satellite cells, but increased during the early stages of myogenic differentiation. By contrast, proliferating satellite cells expressed robust amounts of Pitx3, with levels then decreasing as cells differentiated, although Pitx3 remained expressed in unfused myoblasts. To examine the role of Pitx genes in satellite cell function, retroviral-mediated expression of Pitx1, all Pitx2 isoforms or Pitx3, was used. Constitutive expression of any Pitx isoform suppressed satellite cell proliferation, with the cells undergoing enhanced myogenic differentiation. Conversely, myogenic differentiation into multinucleated myotubes was decreased when Pitx2 or Pitx3 levels were reduced using siRNA. Together, our results show that Pitx genes play a role in regulating satellite cell function during myogenesis in adult.
Introduction
Skeletal muscle has a remarkable ability to repair and regenerate due to the presence of resident stem cells, termed muscle satellite cells, located on the surface of a myofibre ( (Mauro, 1961) , for reviews see (Relaix and Zammit, 2012; Scharner and Zammit, 2011) ). Regulation of satellite cell function during postnatal growth and in adult requires redeployment of many regulatory networks key to controlling developmental myogenesis, for example Notch (Brohl et al., 2012; Mourikis et al., 2012) and BMP signalling (Ono et al., 2011) . Other transcription factors involved in control of muscle stem cell fate and myogenesis in embryos though, have not had their role in adult muscle examined, including the transcription factors paired-like homeodomain transcription factor 2 (Pitx2) and Pitx3 of the bicoid class of homeodomain proteins (Abu-Elmagd et al., 2010; L'Honore et al., 2007) .
Pitx genes encode highly homologous proteins, virtually identical within their homeodomains and varying mainly in the N-terminal region (Gage et al., 1999) . Pitx2 and Pitx3 are involved in development of several tissues, with Pitx2 being fundamental to brain, pituitary, facial structures and heart development (Kioussi et al., 2002; Kitamura et al., 1999 Kitamura et al., , 1997 Lu et al., 1999; Muccielli et al., 1996) , whereas Pitx3 is central to eye and dopaminergic neurone development (Qiu et al., 2008; Smidt et al., 2004 Smidt et al., , 1997 . Indeed, PITX mutations result in developmental disorders in man: with PITX2 mutations causing Axenfeld-Rieger syndrome and mutations in PITX3 underlying Anterior Segment Mesenchymal Dysgenesis and congenital cataracts (Semina et al., 1998 (Semina et al., , 1996 .
Both Pitx2 and Pitx3 are also implicated in developmental myogenesis with myoblasts expressing Pitx2 and Pitx3 Dong et al., 2006; L'Honore et al., 2007; Qiu et al., 2008; Shih et al., 2007a) . Indeed, Pitx2 can positively regulate Myf5 and MyoD expression, members of the myogenic regulatory factor (MRF) family of transcription factors (comprising Myf5, MyoD, Mrf4 and myogenin) that are essential for myogenesis (Abu-Elmagd et al., 2010; L'Honore et al., 2010) . In head myogenesis in particular, Pitx2 actually initiates the myogenic program in extra-ocular muscles Shih et al., 2007a) . Satellite cells express a number of genes utilised during embryonic and foetal muscle development, including the myogenic regulatory factors (Beauchamp et al., 2000; Grounds et al., 1992; Yablonka-Reuveni and Rivera, 1994) , but little is known about the role of Pitx genes in controlling adult myogenesis, other than Pitx2 and Pitx3 are expressed in proliferating satellite cells (Ono et al., 2010) . Pitx1 is the third gene of the family and is involved in development and specification of a number of tissues including first branchial arch derivatives, body wall and hind limb musculature (Gage et al., 1999; Lanctot et al., 1997; Logan and Tabin, 1999; Szeto et al., 1999) , but it is unclear whether this is a direct effect on muscle development. PITX1 is increased in muscle biopsies of patients with Facioscapulohumeral muscular dystrophy (FSHD) (Dixit et al., 2007) , and transgenic muscle-specific PITX1 expression in mice results in a dystrophic phenotype (Pandey et al., 2012) .
Here, we examined the function of Pitx genes in adult muscle satellite cells. Pitx1 was undetectable, while Pitx2 and Pitx3 were modulated in a dynamic and complementary manner in murine satellite cells. Pitx3 was expressed in the nuclei of proliferating satellite cells, before being down-regulated later in myogenic differentiation. However, unfused myoblasts retained Pitx3 protein. Pitx2 had a complementary profile: being at low levels in proliferating cells before being up-regulated during early myogenic differentiation, and being expressed in the nuclei of immature myotubes. To examine the effects of Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3 on myogenic progression in satellite cell-derived myoblasts, we used retroviral-mediated expression. Such constitutive expression revealed that all Pitx proteins suppressed proliferation and enhanced myogenic differentiation. Conversely, myogenic differentiation into multinucleated myotubes was decreased when Pitx2 or Pitx3 levels were reduced using siRNA. Together, our results demonstrate that Pitx2 and Pitx3 genes are redeployed in satellite cells during myogenic progression, so contributing to the regulation of satellite cells for their role in maintenance and repair of skeletal muscle.
Material and methods

Animals
Mice were bred, and experimental procedures carried out, in accordance with British law under the provisions of the Animals (Scientific Procedures) Act 1986, as approved by the King's College London Ethical Review Process committee. C57BL10 male mice aged between 6 and 8 weeks were used for myofibre and satellite cell-derived myoblast preparations. Mice were sacrificed by cervical dislocation.
Myofibre isolation and culture
To study quiescent satellite cells and satellite cell-derived myoblasts retained on a myofibre, extensor digitorum longus (EDL) muscles were dissected and digested for 1.75 h in Dulbecco's Modified Eagle Media with Glutamax (DMEMGlutamax) (Invitrogen) with v/v 1% pen/strep (Sigma) and 0.025% collagenase (Sigma) at 37 1C with 5% CO 2 , before manual disruption with a wide bore glass pipette (as previously described ). Individual liberated myofibres were passed through 5% bovine serum albumin (BSA) (Sigma) coated dishes with DMEMGlutamax (Invitrogen) with v/v 1% pen/strep (Sigma) to remove debris. For non-adherent cultures, myofibres were transferred to 5% BSA (Sigma) coated dishes and DMEMGlutamax (Invitrogen) with v/v 10% horse serum (HS) (Gibco), v/v 0.5% chick embryo extract (CEE) (ICN Flow) and v/v 1% pen/strep (Sigma) before being cultured at 37 1C with 5% CO 2 .
Satellite cell-derived myoblast preparation
To prepare plated satellite cell-derived myoblast cultures, myofibres were isolated and plated at $100 fibres/well in 6 well plates coated with 1 mg/ml Matrigel (Collaborative Research). Muscle fibres were cultured in high-serum proliferation medium comprising DMEMGlutamax (Invitrogen) with v/v 30% foetal bovine serum (FBS) (PAA), 10% HS (Gibco), 1% CEE (ICN Flow), 10 ng/ml basic fibroblast growth factor (bFGF) (Peprotech) 1% pen/strep (Sigma), at 37 1C with 5% CO 2 for 72 h, before being removed to leave the satellite cell-derived myoblasts that had migrated from the myofibre. Myoblasts were then expanded for up to another 48 h. To assess proliferation, myoblasts were cultured in high-serum medium (without bFGF). To induce differentiation, myoblasts were cultured in lowserum differentiation medium comprising of DMEMGlutamax (Invitrogen) with v/v 2% HS (Gibco) and 1% pen/strep (Sigma).
Expression vectors
Murine Pitx cDNAs were cloned into a modified pMSCV-puro vector (Clontech), in which the puromycin resistance gene has been replaced with an internal ribosomal entry site preceding the coding sequence for enhanced green fluorescent protein (IRES-eGFP) (Zammit et al., 2006) . Murine Pitx1 and Pitx2a cDNA (kind gifts from Dr Jacques Drouin) and Pitx2b and Pitx2c (kind gifts from Dr Robert Kelly) were sub-cloned into pMSCV-IRES-eGFP. Pitx3 was cloned from RNA extracted from proliferating satellite cell cultures. All constructs were fully sequenced to ensure fidelity. Retrovirus was packaged in HEK293T cells in the presence of an ecotrophic packaging plasmid, harvested from the culture medium and retroviral titre estimated. Retroviral constructs were tested using Western blot analysis (Supplemental Fig. S1 ).
Retroviral infection
Satellite cell-derived myoblasts were re-plated at 1.5 Â 10 5 cells per well in 6 well dishes (Nunc) pre-coated with Matrigel (Collaborative Research). Cells were maintained in high-serum proliferation medium for 24 h before medium replacement and retroviral infection 1 h later. Cells were incubated at 37 1C under 5% CO 2 with titered control or Pitx-encoding retrovirus and 4 mg/ml polybrene for 4 h before medium replacement to DMEMGlutamax (Invitrogen) with v/v 30% FBS (PAA), 10% HS (Gibco), 1% CEE (ICN Flow), 1% pen/strep (Sigma). Cells were cultured for a further 24 h before being re-plated 5 Â 10 3 and 25 Â 10 3 cells/well on Matrigel (Collaborative Research) coated 8-well chamber slides (Nunc), for proliferation and differentiation assays respectively.
siRNA-mediated Pitx gene knockdown
Satellite cell-derived myoblasts were re-plated at 1.5 Â 10 5 cells per well in 6 well dishes (Nunc) pre-coated with Matrigel (Collaborative Research) and maintained in high-serum proliferation medium for 24 h. Medium was replaced with fresh medium without antibiotic 1 h before siRNA transfection. Stealth siRNA (Invitrogen) and Lipofectamine RNAiMAX (Invitrogen) transfection reagent was prepared as per manufacturer's instructions to give a final working concentration of 30 nM Stealth siRNA. Stealth siRNA against all Pitx2 isoforms, or Pitx3, were assessed for specificity and efficient knockdown of respective genes (supplementary Fig. S2 ). The following siRNA were used in this study Pan-Pitx2 (MSS276338) 5 0 -CCAGCCUCAAUAGCCUGAAUAACUU-3 0 and Pitx3 (MSS237572) 5 0 -UCUGGCUUCACAGCCUGUAUUCUCA-3 0 (Invitrogen). siRNA controls were purchased from Invitrogen. Cells were cultured with transfection reagents for 6 h before medium was replaced to high-serum proliferation medium for a further 24 h. Satellite cell-derived myoblasts were re-plated (as above) for proliferation and differentiation assays.
Quantitative RT-PCR
To assess endogenous gene expression in satellite cells, EDL myofibres were isolated from eight week old, male C57BL10 mice. Muscle fibres were either prepared immediately (4 h after sacrifice and without exposure to serum) or after 24 and 72 h in culture, with low-serum proliferation medium at 37 1C with 5% CO 2 . For each replicate (n¼3) fibres from two mice (4 EDL muscles) were pooled, mildly digested with 0.125% trypsin-EDTA (Sigma) for 12 min, before being manually stripped using a glass pipette to liberate satellite cells.
Subsequent passage through a 40 mm cell sieve (BD) separated myofibres and satellite cells.
Satellite cell-derived myoblasts were prepared as described previously, plated 1.5 Â 10 5 cells per well in Matrigel Fig. 1 . Dynamic Pitx2 and Pitx3 expression during myogenic progression in satellite cells. RNA was prepared from satellite cells manually stripped from extensor digitorum longus (EDL) myofibres immediately after isolation (quiescent) or after 24 or 72 h of activation in non-adherent culture. Myofibres from both EDL muscles of 6 mice were pooled to provide each of the 3 Â quiescent and 3 Â 24 h replicates (n ¼3), whilst pooled myofibre cultures from both EDL muscles from 3 mice were cultured before stripping to give 3 Â 72 h samples (n ¼3). Pitx2 and Pitx3 mRNA levels increased with culture compared to those in quiescent satellite cells when measured using quantitative RT-PCR (A). Expression of Pitx2a, Pitx2b, Pitx2c and Pitx3 was directly compared after 72 h of culture and revealed that Pitx2c and Pitx3 were expressed at the highest levels (B-expressed relative to Pitx2a). Differences in mRNA expression were tested using a two-tailed Student's t-test, where an asterisk denotes p o 0.05. Satellite cells associated with an isolated myofibre were cultured for 72 h and co-immunostained with a specific Pitx2 antibody (red) and either Pax7 (green) or myogenin (green) (C). Satellite cell progeny entering myogenic differentiation (myogenin-positive) were co-immunostained for Pitx2 (C-arrows). Myofibre associated satellite cells infected with Pitx2c-expressing retrovirus were used as a positive control and co-immunostained for eGFP (green) from the IRES-eGFP in the retroviral backbone, and Pitx2 (red) (D). Scale bar equals 100 mm.
(Collaborative Research) coated, 6 well plates. Total RNA was extracted using the RNeasy Kit (Qiagen) and quantified on a Nanodrop ND-1000 spectrophotometer (Labtech). cDNA was prepared from 100 ng of RNA using the Reverse Transcription Kit with genomic DNA wipeout (Qiagen). QPCR was performed on an Mx3005P QPCR system (Stratagene) with MESA Blue qPCR MasterMix Plus and ROX reference dye (Eurogentec).
Primers for Pitx2 isoforms, Pax7, Myf5, MyoD, myogenin and MyHC have been previously described , Martinez-Fernandez et al., 2006 . Primers for Pitx1 (forward 5 0 -TGGACCAACCTCACTGAACC-3 0 and reverse 5 0 -CGCCCAGTT-GTTGTAGGAGT-3 0 ), Pitx3 (forward 5 0 -GAGCACAGTGACTCGGAGAA-3 0 and reverse 5 0 -TGTCAGGGTAGCGATTCCTC-3 0 ) and Mrf4 (forward 5 0 -TAAGGAAGGAGGAGCAAACG-3 0 and reverse 5 0 -CCTGCTGGGTGAA GAATGTT-3 0 ). Relative gene expression was calculated using the Pfaffl method (Pfaffl, 2001) and significance assessed with a Student's t-test.
Immunostaining
Isolated myofibres or plated myoblast preparations were fixed in 4% paraformaldehyde, permeabilised in 0.5% Triton X-100 (Sigma) for 10 min, washed then blocked in 10% v/v swine serum (DAKO) and 10% v/v goat serum (DAKO) diluted in PBS for 30 min at room temperature. Myofibres or plated cultures were incubated in primary antibodies overnight at 4 1C. The following day samples were washed and primary antibodies detected using AlexaFluor conjugated secondary antibodies (Invitrogen) at room temperature for 1 h, before mounting in aqueous mountant containing DAPI (Vectashield).
Primary antibodies used in this study include: mouse anti-Pax7 (DSHB), mouse anti-myogenin clone F5D (DSHB); mouse anti-MyoD clone 5.8A (DakoCytomation), rabbit anti-GFP (Invitrogen), rabbit anti-Phosphorylated-Histone H1 (Upstate/Millipore), rabbit anti-Phosphorylated-Histone H3 (Upstate/Millipore), rat anti-Ki67 (DAKO) and chicken anti-GFP (Invitrogen). Well-characterised rabbit polyclonal antibodies specific for either Pitx1, Pitx2 or Pitx3 were a kind gift from Dr. J. Drouin . The specificity of these anti-Pitx antibodies was also independently validated in this study by immunostaining cells expressing each isoform using retroviral-mediated delivery, Western blot analysis, and siRNA-mediated gene knockdown ( Supplementary Fig. S1 and Fig. S2 ). EdU was detected using the Click-iT EdU kit as per the manufacturer's instructions (Invitrogen).
Images of single fibres were acquired on a Zeiss Axiovert 200 M microscope using a Zeiss AxioCam HRm and AxioVision software version 4.4 (Zeiss) and plated cultures using a Zeiss Axioplan 2 with a Hamamatsu ORCA-ER camera with Openlab 3.1.7 software. Images were adjusted globally for brightness and contrast.
Immunoblot analysis
Satellite cell-derived myoblasts were prepared and infected as described previously. Total protein was extracted, quantified and 10 mg of protein was used for the western blot. Primary antibodies were rabbit polyclonal anti Pan-Pitx (from Jacques Drouin, 1/1000), rabbit polyclonal anti-GFP (Invitrogen, 1/1000) and monoclonal anti-ß-tubulin (E7-c, DHSB, 1/2000) were applied overnight at 4 1C before washing and incubating with HRP-conjugated secondary antibodies (anti-mouse IgG (NA931V, Ge Healthcare, 1/5000)), and anti-rabbit IgG (NA934V, Ge Healthcare,1/5000) applied for 1 h at room temperature. Bands were visualised using the ECL western blotting detection reagents (GE Healthcare).
Results
Pitx expression profile in quiescent and activated satellite cells
Although Pitx expression has been detected in muscle precursors during development L'Honore et al., 2007; Shih et al., 2007a) , little is known of the expression dynamics (Ono et al., 2010) or function of Pitx genes during myogenic progression in muscle satellite cells. We used the isolated myofibre model to explore Pitx expression in quiescent and activated satellite cells, and in satellite cell-derived myoblasts during proliferation and commitment to differentiation. Pitx2a, Pitx2b, Pitx2c and Pitx3 mRNA were detected in quiescent satellite cells stripped from freshly isolated EDL myofibres and levels increased on culture in activating medium (Fig. 1A) , while Pitx1 could not be reliably detected. After 72 h in activation medium, significant increases in all Pitx2 isoforms and Pitx3 mRNA were found (Fig. 1A) . Using the Pfaffl method to account for different primer efficiencies (Pfaffl, 2001) , it was found that Pitx2c and Pitx3 mRNA were the most abundant Pitx isoforms in satellite cellderived myoblasts at 72 h ( Fig. 1B) .
To examine whether Pitx protein followed the gene expression dynamics, we used characterised antibodies against Pitx2 (detecting all Pitx2 isoforms) or Pitx3 . We were unable to detect endogenous Pitx2 or Pitx3 protein in quiescent or newly activated satellite cells associated with a myofibre, due to immunostaining background in the muscle fibre (data not shown). After 72 h in activation medium, many satellite cell-derived myoblasts commit to differentiation and express myogenin, whilst others retain Pax7, representing the self-renewing population (Halevy et al., 2004; Zammit et al., 2004) . Pitx2 protein was clearly detectable in the nuclei of myogenin positive satellite cell-derived myoblasts (Fig. 1C , arrow), implicating Pitx2 in satellite cell differentiation. Antibody fidelity was confirmed by immunostaining cells infected with retroviruses encoding Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3, and infection with a Pitx2c retroviral construct (that also expresses eGFP via an IRES) is illustrated as an example of such positive controls ( Fig. 1D ).
Pitx2 levels are up-regulated during myogenic differentiation
To investigate Pitx gene expression during proliferation, and then throughout the differentiation program through to myoblast fusion into multinucleate myotubes, satellite cells were isolated from EDL myofibres, expanded and then re-plated onto Matrigel-coated culture dishes. Such satellite cell-derived myoblast cultures will continue to proliferate, or can be induced to differentiate in low-serum medium and after $12 h, begin to fuse into myotubes, with the majority fusing to form multinucleate myotubes by 48 h ( Fig. 2A) .
RNA was harvested from proliferating myoblasts, and from those cultured for 6, 12, 24 and 48 h after addition of low-serum differentiation medium. Pitx expression was assessed in parallel with myogenic markers (Fig. 2B) . As myoblasts differentiate, expression of the transcription factors Pax7 and Myf5 decreased. Conversely, myogenic factors associated with differentiation and myotube maturation, such as myogenin and Mrf4, together with myosin heavy chain (MyHC), all increased. MyoD levels were already high in proliferating satellite cells and remained so during the initial stages of myogenic differentiation, before then falling as myotubes matured (Fig. 2B) .
Pitx1 primer efficacy was demonstrated using RNA isolated from satellite cell-derived-myoblasts infected with a Pitx1-encoding retrovirus (data not shown). However, endogenous Pitx1 expression could not be reliably measured in satellite cell-derived myoblasts due to the large number of amplification cycles required to achieve a signal (data not shown), which suggests that endogenous Pitx1 mRNA levels are negligible.
Compared to the levels in proliferating satellite cell-derived myoblasts, expression of all Pitx2 isoforms significantly increased from12 h after induction of differentiation. After 24 h in differentiation medium, levels of Pitx2a had increased 5.6 fold, Pitx2b
3.3 fold and Pitx2c 5.9 fold (po0.05) compared to those measured during proliferation (Fig. 2C) .
A significant increase in Pitx3 levels was measured in satellite cell-derived myoblasts 6 and 12 h after the induction of differentiation. However, Pitx3 mRNA levels then fell by a mean of 36% at 24 h and 81% (p o0.05) after 48 hrs in differentiation medium, compared to levels in proliferating cells (Fig. 2C) . Pitx2 mRNA levels increase during the early phases of differentiation in satellite cell-derived myoblasts. Proliferating plated satellite cell-derived myoblasts isolated from extensor digitorum longus muscles were induced to differentiate in low-serum medium for 6, 12, 24 and 48 h, by which time they had fused to form multinucleated myotubes (A-light field). Scale bar equals 100 mm. Expression of myogenic genes (B) and Pitx transcription factors (C) was assessed during differentiation using quantitative RT-PCR and displayed relative to mRNA levels in proliferating myoblasts (P). As expected Pax7 and Myf5 levels fell during differentiation when compared to those in proliferating cells, while myogenin, MyHC and Mrf4 expression all increased (B). Levels of all Pitx2 isoforms increased during differentiation, while those of Pitx3 transiently rose, before then decreasing (C). Mean7 SEM from 4 mice, where an asterisk denotes significant difference (p o 0.05) in mRNA expression from that in proliferating satellite cells using a two-tailed Student's t-test.
Pitx protein levels are dynamic during myogenic progression of satellite cells
Immunostaining was also used to examine Pitx protein distribution in proliferating and differentiating plated satellite cell-derived myoblasts. There was weak nuclear immunostaining for Pitx2 in Pax7-expressing proliferating satellite cell-derived myoblasts, indicating the presence of low levels of Pitx2 protein (Fig. 3A) . After 24 h in differentiation medium however, the immunosignal for Pitx2 protein was clearly stronger in MyoD or myogenin expressing nuclei of satellite cell-derived myoblasts (Fig. 3B-arrows) , compared to myoblasts not expressing myogenin ( Fig. 3B -arrowhead) . This suggests that Pitx2 protein levels are up-regulated around the time of induction of myogenin expression. Quantification of the number of cells that coimmunostain for Pitx2 and myogenin showed that a mean 7SD of 8177.6% cells expressed both genes 24 h after induction of differentiation, and 8777.6% (n¼3 mice) by 48 h. Pitx2 protein was detected in the myogenin-positive nuclei of MyHC containing multinucleated myotubes at 48 h (Fig. 3C-arrows) .
Proliferating satellite cell-derived myoblasts exhibited robust nuclear immunostaining for Pitx3 protein (Fig. 3D ). However, 24 h after induction of differentiation, decreased immunostaining for Pitx3 protein in myogenin-positive myonuclei (Fig. 3E-arrows) was observed, while myogenin-negative cells retained a Pitx3 immunosignal ( Fig. 3E-arrowheads) . Quantification of the number of cells that co-immunostain for Pitx3 and myogenin (mainly weakly) showed that 60 78.6% cells expressed both genes 24 h after induction of differentiation, and 4573.8% (n ¼3 mice) by 48 h. Although Pitx3 immunostaining was weak (or absent) in many myotube nuclei, Pitx3 could still be detected in the nuclei of a subset of non-fused, myogenin-negative cells ( Fig. 3F-arrowheads) , which are likely reserve cells (Yoshida et al., 1998) .
Pitx proteins inhibit cell cycle progression
We next used retroviral-mediated constitutive expression of Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3, to examine effects on satellite cell function. The retroviral constructs also contain an IRES-eGFP, so that infected cells can be identified. Effects of infection with retroviruses encoding each Pitx isoforms were compared to infection with a control retrovirus expressing just eGFP. Although Pitx1 was not detected convincingly at the mRNA or protein level in satellite cells, we also assessed the effects of constitutive expression of Pitx1, given its implication in FSHD muscle pathology (Dixit et al., 2007) . Constitutive expression using each of the retroviral constructs produced enhanced levels of the relevant Pitx isoform, together with eGFP controlled by the IRES, as assayed using Western blot analysis ( Supplementary Fig. S1 ).
To assess the effect of constitutive retroviral-mediated expression of Pitx transcription factors on proliferation, satellite cellderived myoblasts were isolated from EDL myofibres, expanded in high-serum proliferation medium, then re-plated to produce parallel sister cultures. Cells were infected and 24 h after infection, satellite cell-derived myoblasts were assayed by either coimmunostaining for Phosphorylated-Histone H1 and H3, or measuring EdU incorporation (Fig. 4) .
Phosphorylated-Histone H1 and H3 are dynamically regulated through the cell cycle and the combined Phosphorylated-Histone Fig. 3 . Pitx3 is expressed in proliferating myoblasts, while Pitx2 increases upon myogenic differentiation. Plated satellite cell-derived myoblast cultures were derived from isolated extensor digitorum longus myofibres and maintained in high-serum proliferation medium (A and D) or induced to differentiate for 24 (B and E) or 48 h (C and F). Myoblasts were co-immunostained for Pitx2 or Pitx3 (green) and either Pax7, MyoD, myogenin or MyHC (red). Pitx2 was at low levels in proliferating satellite cells (A), but 24 h after induction of differentiation, strong Pitx2 immunostaining was detected in myogenin-positive nuclei (B-arrows). Myogenin-negative myoblast nuclei had comparatively low levels of Pitx2 protein (B-arrowhead). 48 h after induction of differentiation, strong Pitx2 immunosignal was detected in the nuclei of myotubes identified by myogenin or MyHC immunostaining (C-arrows). Pitx3 was robustly expressed in proliferating myoblasts (D). Pitx3 levels remained robust in myogenin-negative cells during the early stages of differentiation (E-arrowhead), but decreased in myogenin-positive nuclei (E-arrows). By 48 h after induction of differentiation, Pitx3 levels were higher in the nuclei of unfused myoblasts (F-arrowheads) than in the nuclei of myotubes.
Scale bar equals 20 mm.
H1/H3 immunosignal can be used to gauge the stage a cell is at in the cell cycle ((Hendzel et al., 1997; Lu et al., 1994) and Fig. 4A ). Constitutive expression of Pitx1, Pitx2b, Pitx2c or Pitx3 all significantly increased the proportion of satellite cellderived myoblasts in G0, as compared to other stages of the cell cycle, when compared to cells infected with control retrovirus (Fig. 4B) .
Constitutive retroviral-mediated expression of either Pitx1, Pitx2a, Pitx2c, or Pitx3 in satellite cell-derived myoblasts also significantly decreased the percentage that incorporated EdU after a 2-hour pulse immediately prior to fixation, when compared to cells infected with control retrovirus (Fig. 4C ). This indicated that fewer satellite cell-derived myoblasts had entered S-phase during the duration of the EDU pulse.
Combined, these results show that expression of Pitx transcription factors is sufficient to suppress proliferation in expanded satellite cellderived myoblasts.
Pitx proteins enhance myogenic differentiation
To examine the effects of constitutive Pitx expression during myogenic differentiation through to fusion into multinucleated myotubes, parallel sister cultures were infected with retroviral constructs encoding either Pitx1, Pitx2a, Pitx2b, Pitx2c, Pitx3 or control retrovirus. After 24 h in high-serum proliferation medium, infected satellite cell-derived myoblasts were re-plated at equal density and induced to differentiate using low-serum differentiation medium for a further 48 h before fixation and co-immunostaining for either eGFP and Pax7, myogenin or MyHC (Fig. 5) .
Constitutive expression of Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3 resulted in an increase of fusion into multinucleated myotubes, compared to infection with control retrovirus. 48 h after induction of differentiation, numerous thin eGFP/MyHC positive myotubes were observed in cultures infected with Pitx-encoding retroviral constructs (Fig. 5A) . Pitx1, Pitx2a, Pitx2b, Pitx2c, or Pitx3 Fig. 4 . Constitutive Pitx expression reduces proliferation in satellite cell-derived myoblasts. Satellite cell-derived myoblasts from isolated extensor digitorum longus myofibres were infected with Pitx-encoding retroviral constructs or control retrovirus and maintained in high-serum proliferation medium for a further 24 h, before either being co-immunostained for Phosphorylated- Histone H1 and H3 (A and B) , or subjected to a 2 h EdU pulse (C). The expression pattern of Phosphorylated-Histone H1/H3 permits the stage of the cell cycle that a cell is in to be assessed (A). It was found that constitutive expression of Pitx1, Pitx2b, Pitx2c or Pitx3 significantly increased the proportion of cells in G0, compared to cells infected with control retrovirus (B-500 cells/infection/mouse, n ¼4 mice). The percentage of infected eGFP-positive myoblasts that had incorporated EdU was also quantified, and revealed that all Pitx isoforms, except Pitx2b, reduced the rate of proliferation compared to cells infected with control retrovirus (C-mean 343 cells/infection/mouse, n ¼3 mice). Mean7 SEM are displayed where Significant difference between infection with each Pitx isoform and control retrovirus was tested using a two-tailed Student's t-test, where an asterisk denotes p o 0.05.
constitutive expression significantly increased the percentage of eGFP-positive cells with myogenin when assayed 48 h after induction of differentiation, to a mean7SEM of 93.072.5% for Pitx1, 95.070.7% for Pitx2a, 90.071.5% for Pitx2b, 95.5 71.1% for Pitx2c and 93.5 70.7% for Pitx3, compared to 83.670.9% in cells infected with control retrovirus (p o0.05, n¼ 3 mice- Fig. 5B ).
To ascertain if constitutive Pitx expression increased myoblast fusion, the number of nuclei in eGFP-positive myotubes and nonfused eGFP-positive myoblasts was counted 48 h after induction of differentiation. Consistent with the increased number of nuclei expressing the differentiation marker myogenin (Fig. 5B) , infection with any Pitx-encoding retroviral construct significantly increased Fig. 5 . Constitutive expression of Pitx1, Pitx2 or Pitx3 enhances myogenic differentiation in satellite cell-derived myoblasts. Satellite cell-derived myoblasts from isolated extensor digitorum longus myofibres were infected and 48 h after addition of low-serum differentiation medium, co-immunostained for eGFP (green) and either Pax7, myogenin or MyHC (red). Constitutive expression of any Pitx gene increased the percentage of infected (eGFPþ ve) cells expressing myogenin (B) and the percentage of nuclei included in eGFP þve multinucleated myotubes (A and C), compared to control-infected cultures (mean of 730 cells/infection/mouse assayed, n¼ 3 mice). However, the percentage of eGFPþve myoblasts co-expressing Pax7 was significantly reduced compared to control (D-mean of 1384 cells/infection/mouse assayed, n¼3/4 mice). Mean7 SEM is displayed, with significant difference between constitutive expression of each Pitx isoform and the control retrovirus denoted with an asterisk, where p o0.05 when tested using a two-tailed Student's t-test. Scale bar represents 50 mm.
the fusion index, with an average7SEM percentage of myonuclei in eGFP-positive myotubes increasing to 85.072.9% after constitutive Pitx1 expression, to 84.573.8% for Pitx2a, to 80.073.6% for Pitx2b, to 88.471.0% for Pitx2c and to 87.471.4% by Pitx3, compared to 68.073.6% in controls (po0.05, n¼3 mice, Fig. 5C ).
As constitutive expression of Pitx transcription factors increased myoblast differentiation, sister cultures were also co-immunostained for eGFP and Pax7, and the number of non-fused myoblasts quantified (Fig. 5D) . A reduction in the number of Pax7-positive myoblasts was observed 48 h after induction of differentiation (Fig. 5D) , consistent with the increase in myotube formation ( Fig. 5A and C) . In control cultures, a mean 7SEM of 21.5 72.5% of eGFP-positive cells contained Pax7, but this was significantly reduced by constitutive expression of any Pitx isoform to o10% (po0.05, n¼3/4 mice, Fig. 5D ).
siRNA-mediated reduction of Pitx2 or Pitx3 levels suppress myogenic differentiation
To next assess the effects of reducing Pitx2 or Pitx3 levels in satellite cells, we used siRNA to either simultaneously knock down all three Pitx2 isoforms (siPan-Pitx2) or just Pitx3 (siPitx3). As endogenous levels of Pitx1 were found to be negligible in satellite cell-derived myoblasts, siRNA knockdown was not performed. To test the efficiency of knockdown, RNA was prepared from proliferating satellite cell-derived myoblasts isolated from EDL muscles 24 h after transfection with either Pan-Pitx2 or Pitx3 siRNA. There was an 480% reduction in respective mRNA levels measured by quantitative RT-PCR ( Supplementary Fig. S2a ). Satellite cell-derived myoblasts, transfected with Pan-Pitx2, or Pitx3 siRNA were also induced to differentiate for 48 h before cultures were coimmunostained for Pitx2 or Pitx3 and myogenin. In control siRNA transfected cultures, Pitx2 protein was detected in myotube nuclei, whilst immunostaining in sister cultures exposed to Pan-Pitx2 siRNA exhibited decreased nuclear immunostaining ( Supplementary Fig.  S2b ). In cultures transfected with control siRNA, strong Pitx3 immunosignal was detected in non-fused satellite cell derived myoblasts, which was clearly reduced in sister cultures transfected with Pitx3 siRNA ( Supplementary Fig. S2c) .
Expanded proliferating satellite cell-derived myoblasts were transfected with control, Pan-Pitx2, or Pitx3 siRNA and 24 h later, pulsed with EdU for 2 h and the proportion of cells incorporating the label determined. Reducing the levels of Pitx2 isoforms resulted in more cells incorporating EDU (Fig. 6A) . Satellite cell-derived myoblast cultures transfected with control, Pan-Pitx2 or Pitx3 siRNA were also induced to differentiate by switching to low-serum medium, and 48 h later fixed and coimmunostained for MyHC and Ki67. Suppressing Pitx2 or Pitx3 levels reduced the percentage of satellite cell-derived myoblasts fused into myotubes ( Fig. 6B and D) and increased the percentage of non-fused Ki67-expressing proliferating cells ( Fig. 6C and D) .
Discussion
Pitx genes have been shown to regulate skeletal muscle development, and here we have examined if these three genes also play a role in controlling myogenesis in adult. We found that Pitx2 and Pitx3 are expressed in a dynamic fashion during myogenic progression in muscle satellite cells, while Pitx1 was undetectable at any stage. All Pitx2 isoforms were detectable in proliferating satellite cell-derived myoblasts, with levels then increasing during early myogenic differentiation. Pitx3 was expressed in proliferating satellite cells, but levels then fell as cells differentiated and fused into myotubes. Pitx3 protein however, remained detectable in myogenin-negative unfused cells.
Hitherto, examination of Pitx gene expression and function in myogenesis has largely been confined to development. In the skeletal muscle lineage, Pitx2 is expressed in myoblasts concomitantly with MyoD and myogenin in trunk and limb musculature development, indicating that Pitx2 is present in the early phases of myogenic differentiation L'Honore et al., 2007; Qiu et al., 2008; Shih et al., 2007a; Shih et al., 2008) . Pitx3 has been detected in both myotome (possibly preceding MRF expression) and in myogenin positive myoblasts of the developing limb , as well as by b-galactosidase activity in differentiated muscle of Pitx3 nlacZ mice . In adult, we have previously shown that Pitx2 and Pitx3 message can be detected in proliferating myoblasts (Ono et al., 2010) , and most muscles of adult Pitx2 LacZ/ þ mice exhibit robust reporter expression (Shih et al., 2007b) .
To examine both the effects of Pitx genes on satellite cell function, and model potential increases of PITX1 in FSHD, we used retroviral-mediated constitutive expression. Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3 all had similar effects: satellite cell proliferation was reduced, while myogenic differentiation was promoted. There is considerable sequence homology between Pitx genes: for example, Pitx2 and Pitx3 are identical across their DNA binding homeodomains (Gage et al., 1999) . Furthermore, Pitx transcription factors can bind and activate similar DNA targets (Gage and Camper, 1997; Kitamura et al., 1997; Lamba et al., 2008; Tremblay et al., 2000) , can have shared synergistic partners (Poulin et al., 2000; Tremblay et al., 2000) and Pitx isoforms can interact (Cox et al., 2002) . When constitutively expressed in sister cultures from a common expanded primary satellite cell-derived myoblast preparation, there is probably a similar repertoire of available target genes and cofactors. The similarity in Pitx protein sequence presumably means that they then activate the same cohort of genes, leading to the common effect we observed of promoting differentiation. However, at different points in myogenic progression, target gene or co-factor availability and/or post-translational Pitx modification (Briata et al., 2003; Gherzi et al., 2010) could facilitate different roles for endogenous Pitx2 and Pitx3 in satellite cells.
When Pitx2 or Pitx3 levels were reduced using siRNA, we found that myogenic differentiation into multinucleated myotubes was decreased, with more cells remaining in cell cycle. Constitutive knockout of Pitx2 is embryonic lethal, with failure of body wall closure, cranial facial and ocular defects, right pulmonary isomerism and severe cardiac abnormalities (Kitamura et al., 1999) . However, conditional Pitx2 knockout in extraocular muscle in adult mice has implicated Pitx2 in the maintenance of the differentiated muscle phenotype (Zhou et al., 2009) . By contrast, deletion of Pitx3 does not affect mouse viability, with no drastic effects on skeletal muscle during developmental myogenesis, possibly by virtue of up-regulation and compensation by Pitx2, highlighting their overlapping and partially redundant roles in myogenesis .
Pitx2 has been studied extensively in cardiac development where there is evidence that it can act to either enhance or inhibit (Galli et al., 2008) cardiomyocycte proliferation. In developing chick in vivo or in micromass cultures, overexpression of Pitx2 isoforms leads to an increased number of differentiated myocytes, but whether this is direct, or due to enhanced proliferation, is unclear (Abu-Elmagd et al., 2010) .
Pitx gene function has also been widely investigated in immortalised myoblasts. Consistent with our observations, knockdown of Pitx2 in immortalised C2C12 myoblasts reduces MyoD and myogenin expression, and inhibits myoblast differentiation (Gherzi et al., 2010) . However, Pitx2 can also promote cell proliferation and Cyclin D1/D2 mRNA stabilisation in immortalised myoblast cell lines (Briata et al., 2003; Kioussi et al., 2002; Lozano-Velasco et al., 2011; Martinez-Fernandez et al., 2006) . During proliferation, Pitx2 associates with the Cyclin D1-stabilising complex, but thymoma viral proto-oncogene 2 (Akt2)-mediated phosphorylation of Pitx2 occurs on induction of myogenic differentiation and results in reduced Pitx2 association and destabilisation of the complex (Briata et al., 2003; Gherzi et al., 2010) . Conversely the cyclin-dependent kinase inhibitor p21 has been identified as a Pitx2 target gene (Cao et al., 2010; Shi et al., 2010) . To maintain proliferation, Pitx2 transcriptional activity is also suppressed by the physical interaction of Tbx1 with the Cterminus of Pitx2 (Cao et al., 2010) . Thus, the phosphorylation state of Pitx2, and/or protein interactions, can alter its function during myoblast proliferation or differentiation. This implies that Pitx2 is able to augment cell cycle arrest and differentiation in the absence of pro-proliferative co-factors, whose reduction is an important regulatory step for myoblast differentiation. In addition, analysis of Pitx2 function in immortalised cell lines, that have altered cell cycle regulation and a markedly reduced ability to spontaneously differentiate, may exaggerate the importance of Pitx2 during myoblast proliferation.
The moderate Pitx expression achieved in a large proportion of cells using retroviral-mediated delivery in our study (Supplemental Fig. S1 ), rather than the high levels in relatively few cells after transfection of plasmids, could also contribute to differences between observations in expanded primary satellite cells and immortalised cell lines (Kioussi et al., 2002; Lozano-Velasco et al., 2011; Martinez-Fernandez et al., 2006) . For example, transfection of CMV-Pitx2c or CMV-Pitx3 expression vectors only have effects at high doses in the immortalised Sol8 myoblast line. At low dose (2 mg) there is a large increase in Pitx2c mRNA levels, but no effects on proliferation or differentiation. At higher doses (4 or 8 mg-where 8 mg increases mRNA levels by $ 8000 fold), then increased proliferation and inhibition of differentiation are observed. Transfection of CMV-Pitx3 has no effects on proliferation at any dose (2, 4, or 8 mg), and only inhibits differentiation at the highest level ( 4500 fold) (Lozano-Velasco et al., 2011) .
In summary, this work has identified dynamic expression of Pitx2 and Pitx3 in satellite cells from adult muscle and revealed that they can act to promote cell cycle exit and augment myogenic differentiation. Thus our data show that Pitx2 and Pitx3 can be added to the complex regulatory networks that not only control muscle development (e.g. ), but also play a role in regulating regenerative myogenesis.
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